Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Milad Bahmanof"'
Autor:
Spencer E. Brightman, Martin S. Naradikian, Rukman R. Thota, Angelica Becker, Leslie Montero, Milad Bahmanof, Ashmitaa Logandha Ramamoorthy Premlal, Jason A. Greenbaum, Bjoern Peters, Ezra E.W. Cohen, Aaron M. Miller, Stephen P. Schoenberger
Publikováno v:
JCI Insight, Vol 8, Iss 2 (2023)
CD4+ T cells play a critical role in antitumor immunity via recognition of peptide antigens presented on MHC class II (MHC-II). Although some solid cancers can be induced to express MHC-II, the extent to which this enables direct recognition by tumor
Externí odkaz:
https://doaj.org/article/269a1b54d04f495aa248feef28743e01
Supplementary Figure 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83304318c4336af67fa6f72f1afd932b
https://doi.org/10.1158/2326-6066.22537039.v1
https://doi.org/10.1158/2326-6066.22537039.v1
Adoptive cellular therapy (ACT) using T-cell receptor (TCR)–engineered lymphocytes holds promise for eradication of disseminated tumors but also an inherent risk of pathologic autoimmunity if targeted antigens or antigenic mimics are expressed by n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c564527832deb704aa14b4f7184a4e8f
https://doi.org/10.1158/2326-6066.c.6548305.v1
https://doi.org/10.1158/2326-6066.c.6548305.v1
Legend for supplementary Figure 1 in Word format
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2106e02fccdf251ed4bf1eb0df359450
https://doi.org/10.1158/2326-6066.22537042.v1
https://doi.org/10.1158/2326-6066.22537042.v1
Autor:
Ezra E.W. Cohen, Bjoern Peters, Milad Bahmanof, Kim McConnell, Angela Frentzen, Roxanne Habbaba, Leslie Montero, Jason A. Greenbaum, Luise Westernberg, Ashmitaa Logandha Ramamoorthy Premlal, Zeynep Kosaloglu-Yalcin, Aaron M. Miller, Grégory Seumois, Elaine Eng, Alessandro Sette, Amanda Natsuhara, Stephen P. Schoenberger
Publikováno v:
Journal of Clinical Oncology. 39:2615-2615
2615 Background: Neoantigens (NeoAg) are key targets for personalized immunotherapy but efficient methods for their systematic identification and therapeutic targeting remain elusive. We developed a methodology to reliably identify and verify somatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4df3dc9e22ab6dac7d09bac2cd6a0c7
https://doi.org/10.1200/jco.2021.39.15_suppl.2615
https://doi.org/10.1200/jco.2021.39.15_suppl.2615
Publikováno v:
Cancer Immunology Research
Cancer immunology research, vol 7, iss 1
Cancer Immunol Res
Cancer immunology research, vol 7, iss 1
Cancer Immunol Res
Adoptive cellular therapy (ACT) using T-cell receptor (TCR)–engineered lymphocytes holds promise for eradication of disseminated tumors but also an inherent risk of pathologic autoimmunity if targeted antigens or antigenic mimics are expressed by n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c572807488612bbde933e35fa8feabc
Autor:
Martin S. Naradikian, Leslie Montero, Samantha Hall, Milad Bahmanof, Rukman Thota, Luise Sternberg, Jerome Lane, Zeynep Kosaloglu-Yalcin, Manasa Lanka, Aaron Miller, Bjoern Peters, Ezra Cohen, Stephen Schoenberger
Publikováno v:
Cancer Research. 79:1439-1439
Neoantigens (NeoAg) offer attractive therapeutic targets for directing a patient’s immune response to the immunogenic subset of mutations expressed exclusively by their cancer cells. Despite the specificity with which NeoAg enable tumor recognition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24fcd766f846cf420891c3e7f043ab74
https://doi.org/10.1158/1538-7445.am2019-1439
https://doi.org/10.1158/1538-7445.am2019-1439
Autor:
Martin Souren Naradikian, Leslie Montero, Samantha Hall, Rukman Thota, Angela Frentzen, Milad Bahmanof, Luise Sternberg, Jerome Lane, Zeynep Kosaloglu-Yalcin, Manasa Lanka, Aaron Miller, Bjoern Peters, Ezra Cohen, Stephen Schoenberger
Publikováno v:
The Journal of Immunology. 202:134.1-134.1
Neoantigens (NeoAg) offer attractive therapeutic targets for directing a patient’s immune response to the immunogenic subset of mutations expressed exclusively by their cancer cells. Despite the specificity with which NeoAg enable tumor recognition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b60dad383961257a37a82b3c8d05cda
https://doi.org/10.4049/jimmunol.202.supp.134.1
https://doi.org/10.4049/jimmunol.202.supp.134.1
Autor:
Manasa Lanka, Pandurangan Vijayanand, Stephen P. Schoenberger, Allesandro Seatte, Milad Bahmanof, Ezra E.W. Cohen, Jason A. Greenbaum, Leslie Montero Cuencac, Ashmitaa Logandha Ramamoorthy Premlal, Zeynep Koasaloglu-Yalcin, Aaron M. Miller, Bjoern Peters, Luise Sternberg
Publikováno v:
Cancer Immunology Research. 7:PR12-PR12
Accurate identification of tumor-specific neoantigens (NeoAg) is essential for the development of effective personalized cancer vaccines and cellular immunotherapies. The success rates for purely computational approaches which rely on predicted HLA-b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00cad8d74dc59a1f4e3f0503219042b1
https://doi.org/10.1158/2326-6074.cricimteatiaacr18-pr12
https://doi.org/10.1158/2326-6074.cricimteatiaacr18-pr12